Deals & Corporate Governance

  • January 02, 2024

    Lab Workers Were Fired Lawfully, Mich. Hospital Says

    A Michigan hospital urged a federal judge to reject a National Labor Relations Board official's bid to reinstate 12 lab workers fired for staging a walkout during an organizing drive, claiming the union ignored the National Labor Relations Act's requirement for hospitals to be notified of walkouts in advance.

  • January 02, 2024

    UPMC Hit With OT Class Suit By Respiratory Therapist

    The University of Pittsburgh Medical Center's Harrisburg hospital and a staffing company have been misclassifying respiratory therapists as independent contractors and cheating them out of overtime wages, a former worker alleged in a proposed class action in Pennsylvania state court.

  • January 01, 2024

    5 Policy Moves Benefits Attys Should Watch For In 2024

    Benefits lawyers will be on the lookout for final rules on the scope of the Employee Retirement Income Security Act and parity for mental versus physical healthcare coverage, as well as following the progress of a bill making technical corrections to existing retirement policy. Here are five developments that will be on attorneys' radar in the new year.

  • January 01, 2024

    Washington State Legislation To Watch In 2024

    Concern over access to abortion services and gender-affirming care is prompting Washington state lawmakers to consider a law this year that could give the state more oversight over hospital mergers.

  • January 01, 2024

    Washington Cases To Watch In 2024

    In the coming year, appellate courts are set to decide challenges involving Washington state's capital gains and business taxes as well as a group of PCB poisoning cases against chemical giant Monsanto that have so far racked up more than $1.7 billion in jury awards. Here are some of the top cases to watch in the Evergreen State in 2024.

  • January 01, 2024

    Retail Cases To Watch In 2024

    A wide variety of cases are likely to keep retail industry attorneys busy in 2024, including high-profile antitrust actions against Amazon and Google, a growing number of greenwashing disputes, and skirmishes between major retailers and their increasingly unionized workforces.

  • January 01, 2024

    Trials To Watch In 2024

    Major trials coming down the pike in 2024 include a wealthy Russian art collector's suit against Sotheby's, first bellwethers in multidistrict litigation over allegations Chiquita funded a violent group in Colombia, and a criminal case against U.S. Sen. Bob Menendez. Here's a rundown.

  • January 01, 2024

    New Jersey Legislation To Watch In 2024

    New Jersey lawmakers returned to Trenton this November after 2023's legislative general election for one last session before the incumbent and the newly elected are sworn-in this January. The nearly two-month period — known as a lame-duck session — is often a turbulent time when bills can be rushed through committees and hearings.

  • January 01, 2024

    Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024

    The 2024 appellate almanac is looking lively after eye-popping opinions and arguments in 2023's homestretch. As the new year begins, several circuit splits seem more serious, ideological imbalances are in the spotlight, and luminaries of the U.S. Supreme Court bar are locked in a burgeoning battle over alleged corporate complicity in terrorism.

  • January 01, 2024

    The Biggest Cases To Watch In Native American Law This Year

    Disputes over administrative healthcare costs for tribes that could cost the federal government billions and Voting Rights Act cases that have the potential to undo rulings in several states all gained speed in 2023 with legal experts predicting major decisions out of the appellate courts in the new year.

  • January 01, 2024

    Gov't Contracting Policies To Watch In 2024

    The policy changes federal contractors can expect to see in 2024 include the finalization of a contentious emissions disclosure rule, changes to standards underpinning federal cybersecurity programs and the potential for the U.S. government to exercise more purchasing power. Here, Law360 previews important upcoming policy changes that are likely to affect federal contractors in 2024.

  • December 22, 2023

    Covington-Led Bristol Myers To Buy Karuna In $14B Deal

    Covington & Burling LLP-advised Bristol Myers Squibb said Friday it has agreed to buy Boston-based biotechnology company Karuna Therapeutics Inc. for $14 billion, leading Karuna's stock to jump more than 47% in pre-market trading. 

  • December 21, 2023

    The 5 Biggest First Circuit Rulings Of 2023

    From the "Varsity Blues" college admissions case to a sprawling multidistrict suit against GlaxoSmithKline, the nation's smallest appellate circuit exerted some outsized influence on novel legal issues in 2023. Here are five of the most significant opinions from the Boston-based First Circuit.

  • December 21, 2023

    Cigna Overpayment Claim Tossed In Chuck Close Benefit Suit

    A New York federal judge tossed Cigna's claim Thursday that alleged the artist Chuck Close was over-reimbursed for healthcare claims, ruling the insurer based its bid to claw back cash from Close's estate on a federal benefits law section that didn't allow for money damages.

  • December 21, 2023

    Workers Say Cos. Paid Prevailing Wages To Fake Employees

    Three construction firms tasked with erecting a cancer hospital paid prevailing wages to fake employees while compensating their real workforce at illegally low rates, a group of workers has told a Maryland federal court in a proposed class and collective action.

  • December 21, 2023

    FTC, DOJ End 2023 With New Guidance, Lingering Challenges

    Federal Trade Commission and U.S. Department of Justice competition enforcers are ending 2023 with a mixed track record full of failed criminal prosecutions and contentious civil enforcement, but capped by a crucial win for vertical enforcement and the issuance of new merger guidelines.

  • December 21, 2023

    Judge OKs Mass. Hospital Workers' $500K ERISA Settlement

    A federal magistrate judge in Massachusetts on Thursday signed off on a $500,000 deal settling claims from a healthcare system's current and former employees that alleged the company paid more than double what it should have in fees to two companies that administered employee retirement funds.

  • December 21, 2023

    Finnish Asset Manager Sells 17 Properties For €100M

    A unit of Finland's eQ Group agreed Thursday to sell 17 healthcare properties to an affiliate of Danish real estate investment company Nrep for roughly €100 million ($110 million) in a deal aimed at improving efficiency for its Helsinki operations.

  • December 21, 2023

    Conn. Anesthesiologists Get $1.9M Placeholder In Billing Row

    A Connecticut judge granted the state's chapter of the North American Partners In Anesthesia PC a $1.9 million prejudgment remedy in its billing suit against a hospital, ruling that the anesthesiology organization has shown it will likely get at least that much in damages for its claims.

  • December 21, 2023

    Nelson Mullins Brings On DLA Piper Health Pro In Fla.

    Nelson Mullins Riley & Scarborough LLP picked up a new of counsel who focuses on healthcare mergers and acquisitions in Boca Raton from DLA Piper.

  • December 21, 2023

    Exxon, Chevron Top 2023's 10 Largest M&A Deals

    Exxon and Chevron surprised market observers with two October megadeals that shot right to the top of the 10 largest mergers and acquisitions of 2023, eclipsing a $43 billion cancer biotech buy, a $42 billion Johnson & Johnson split-off, and a near-$30 billion cybersecurity software firm purchase. Here, Law360 recaps the 10 largest deals of 2023.

  • December 20, 2023

    11 Deals That Shaped Healthcare And Life Sciences In 2023

    The healthcare industry's appetite for mergers and acquisitions waned considerably this year, with both the number and size of deals falling well short of recent years. But that didn't make for a slow 2023, with segments like hospital systems showing renewed activity and major announcements in biotech that signaled a careful but growing appetite from the biggest players.

  • December 20, 2023

    Biochemical Co. Amyris OK'd To Sell Celebrity Brands

    Bankrupt biochemical company Amyris Inc. can move forward with plans to sell its remaining consumer brands, a Delaware bankruptcy judge ruled Wednesday, after an auction last week raked in winning bids totaling $6 million.

  • December 20, 2023

    Nursing Facility Buyers Sue To Force 'Upset' Seller To Close

    The buyers of a portfolio of 17 skilled nursing facilities in North Carolina and South Carolina sued in federal court Wednesday to force a closing after the seller became "upset" at a change in the nearly $300 million transaction and stopped negotiating.

  • December 20, 2023

    Tort Report: $120M Med Mal Verdict Sets NY Record

    A record $120 million medical malpractice verdict in New York and an unexpected dramatization of the Gwyneth Paltrow ski injury trial lead Law360's Tort Report, which compiles recent personal injury and medical malpractice news that may have flown under the radar.

Expert Analysis

  • Establishing A Record Of Good Faith In Mediation

    Author Photo

    Viacom v. U.S. Specialty Insurance, and other recent cases, highlight the developing criteria for determining good faith participation in mediation, as well as several practical tips to establish such a record, says Richard Mason at MasonADR.

  • ABA Opinion Should Help Clarify Which Ethics Rules Apply

    Author Photo

    A recent American Bar Association opinion provides key guidance on interpreting ABA Model Rule 8.5's notoriously complex choice-of-law analysis — and should help lawyers authorized to practice in multiple jurisdictions determine which jurisdiction's ethics rules govern their conduct, say attorneys at HWG.

  • How Cannabis Cos. Can Keep Up With Privacy Compliance

    Author Photo

    With the cannabis industry's rapid growth and access to sensitive consumer information, and the ever-changing patchwork of state data privacy laws, it is becoming increasingly important for marijuana businesses to treat cybersecurity as a significant risk and management priority, say attorneys at Goodwin.

  • 4 Ways To Reboot Your Firm's Stalled Diversity Program

    Author Photo

    Law firms that have failed to see real progress despite years of diversity initiatives can move forward by committing to tackle four often-taboo obstacles that hinder diversity, equity and inclusion efforts, says Steph Maher at Jaffe.

  • DOJ's Google Sanctions Motion Shows Risks Of Auto-Deletion

    Author Photo

    The U.S. Department of Justice recently hit Google with a sanctions motion over its alleged failure to preserve relevant instant-messaging communications, a predicament that should be a wake-up call for counsel concerning the danger associated with automatic-deletion features and how it's been handled by the courts, say Oscar Shine and Emma Ashe at Selendy Gay.

  • What To Expect From A Litigation Finance Industry Recession

    Author Photo

    There's little data on how litigation finance would fare in a recession, but a look at stakeholders' incentives suggests corporate demand for litigation finance would increase in a recessionary environment, while the number of funders could shrink, says Matthew Oxman at LexShares.

  • J&J Unit Ch. 11 Case Shows Texas 2-Step May Be Wrong Move

    Author Photo

    The Third Circuit's recent ruling in the Chapter 11 case of Johnson & Johnson's talc-related damages unit raises new questions about the viability of divisional merger transactions as a means to manage mass tort liabilities through bankruptcy, especially when there is a robust funding arrangement, say attorneys at Mayer Brown.

  • Del. Ruling Could Affect D&O Claims Beyond SPACs

    Author Photo

    A Delaware state court recently held in Clover Health v. Berkley Insurance that directors and officers of a post-merger entity were insured persons under a special-purpose acquisition company's D&O policy, a ruling that could have potential ramifications for future D&O claims in Delaware outside of SPAC deals, say Geoffrey Fehling and Janine Hanrahan at Hunton.

  • Breaking Down Maryland's Adult-Use Cannabis Bill

    Author Photo

    Maryland voters approved adult-use cannabis in November and state lawmakers have recently introduced a bill to create a regulatory framework for its cultivation, production and sale, but questions remain on blackout periods for licensees, vertical integration, a lack of protection for off-the-job marijuana use and more, say attorneys at Fox Rothschild.

  • The Limits Of Arbitration Provisions In The ERISA Context

    Author Photo

    Although courts have viewed the Federal Arbitration Act as strongly favoring the enforcement of arbitration provisions, two recent decisions from the District of Delaware and the Tenth Circuit demonstrate that arbitration provisions that expressly forbid planwide relief are not likely to be enforced in ERISA cases seeking such relief, says Elizabeth Hopkins at Kantor & Kantor.

  • Justices Leave Questions Open On Dual-Purpose Atty Advice

    Author Photo

    The U.S. Supreme Court's recent dismissal of In re: Grand Jury on grounds that certiorari was improvidently granted leaves unresolved a circuit split over the proper test for deciding when attorney-client privilege protects a lawyer's advice that has multiple purposes, say Susan Combs and Richard Kiely at Holland & Hart.

  • Would Proposed FTC Noncompete Ban Apply To Nonprofits?

    Author Photo

    Amanda Wait and Abraham Chang at Norton Rose discuss whether the Federal Trade Commission's recently proposed noncompete ban applies to nonprofits, and how to move forward while carefully considering the impact of this rule on business practices.

  • 118th Congress: Investigative Tools And Potential Defenses

    Author Photo

    As federal lawmakers’ investigative priorities for this term become clearer, potential subjects of congressional investigations must understand the tools at Congress’ disposal, as well as their own available defenses, to effectively navigate these inquiries, say attorneys at Gibson Dunn.